GSK Pledge To Lower Drug Prices In Least-developed Countries To Have Minimal Impact In Asia

HONG KONG - GlaxoSmithKline's push to lower drug prices in the world's least-developed markets is not likely to have much of an impact for customers in larger and richer Asian markets but it could forestall competition from generic manufacturers